AN UNBIASED VIEW OF BOSENTAN

In WHO Practical Course II people, contemplate no matter whether the benefits of bosentan are adequate to offset the potential risk of hepatotoxicity, which can preclude future use as their disease progresses.There are many potential confounders, eg, Serious adaptation, symptom exacerbation by co-morbid situations like lung fibrosis and anemia. It